HomePLYX • NASDAQ
add
Polaryx Therapeutics Inc
Previous close
$2.41
Day range
$3.09 - $5.05
Year range
$2.20 - $48.91
Avg Volume
56.56K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 974.00K | 26.33% |
Net income | -1.43M | -85.47% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.74M | — |
Total assets | 5.98M | — |
Total liabilities | 682.00K | — |
Total equity | 5.30M | — |
Shares outstanding | 47.03M | — |
Price to book | 21.91 | — |
Return on assets | -51.12% | — |
Return on capital | -56.97% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.43M | -85.47% |
Cash from operations | -887.00K | 33.41% |
Cash from investing | — | — |
Cash from financing | 3.33M | — |
Net change in cash | 2.44M | 283.26% |
Free cash flow | -113.75K | — |
About
Founded
2014
Headquarters
Website
Employees
11
